Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06581692
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-23
Brief Title:
Non-invasive Monitoring of Miscarriage
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Non-invasive Monitoring of Miscarriage
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test This study aims to determine the level of cell-free DNA cfDNA in early pregnancy and compare the results with those of product of conception POC testing in concordance with standard karyotyping
Detailed Description:
Pregnancies achieved by assisted reproductive technologies ART are closely monitored therefore miscarriages that occur very early in the pregnancy are frequently meticulously recorded and reported On the other hand spontaneous abortion rates among naturally occurring conceptions are notoriously hard to quantify and are often overstated when using criteria from assisted reproductive technologies Additionally women who have undergone treatment with ART are a particular population with traits that can make them more vulnerable to spontaneous abortions
cfDNA would be extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test This study aims to determine the level of cell-free DNA cfDNA in early pregnancy and compare the results with those of product of conception POC testing in concordance with standard karyotyping
cfDNA would be extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test This study aims to determine the level of cell-free DNA cfDNA in early pregnancy and compare the results with those of product of conception POC testing in concordance with standard karyotyping
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None